The MDA's annual conference highlighted recent breakthroughs and the outlook for future care in the neuromuscular disease ...
Dyne Therapeutics is advancing z-rostudirsen toward approval for DMD after data showed increased dystrophin and early ...
Columnist Betty Vertin says her three sons with DMD may not have a big social life, but they have a big family that makes up ...
In 2018, when Nell Choi was 9 years old, she began experiencing symptoms that led to hospitalization and a diagnosis of ...
The evidence for Elevidys is growing, and Sarepta is working to make the DMD treatment widely available, the company's ...
Columnist Shalom Lim is using his lived experience with Duchenne muscular dystrophy to consult with organizations about ...
Capricor has reapplied for FDA approval of deramiocel, its therapy for DMD-related heart disease, and expects a decision by ...
Dyne Therapeutics' Z-basivarsen led to gains in motor function and cognition for myotonic dystrophy type 1, and is entering a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results